These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 21737130)
1. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130 [TBL] [Abstract][Full Text] [Related]
2. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777 [TBL] [Abstract][Full Text] [Related]
3. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Ledur PF; Liu C; He H; Harris AR; Minussi DC; Zhou HY; Shaffrey ME; Asthagiri A; Lopes MB; Schiff D; Lu YC; Mandell JW; Lenz G; Zong H Neuro Oncol; 2016 Oct; 18(10):1413-24. PubMed ID: 27106408 [TBL] [Abstract][Full Text] [Related]
4. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381 [TBL] [Abstract][Full Text] [Related]
5. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577 [TBL] [Abstract][Full Text] [Related]
6. MADM gives new insights into gliomagenesis. Lei L; Canoll P J Mol Cell Biol; 2011 Oct; 3(5):273-5. PubMed ID: 21926086 [TBL] [Abstract][Full Text] [Related]
7. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000 [TBL] [Abstract][Full Text] [Related]
8. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma. Solga AC; Gianino SM; Gutmann DH Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450 [TBL] [Abstract][Full Text] [Related]
9. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities. Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201 [TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype. Sreedharan S; Maturi NP; Xie Y; Sundström A; Jarvius M; Libard S; Alafuzoff I; Weishaupt H; Fryknäs M; Larsson R; Swartling FJ; Uhrbom L Cancer Res; 2017 Feb; 77(3):802-812. PubMed ID: 28115362 [TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche. Zou Y; Niu W; Qin S; Downes M; Burns DK; Zhang CL Mol Cell Biol; 2012 Dec; 32(23):4811-20. PubMed ID: 23028043 [TBL] [Abstract][Full Text] [Related]
12. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. Jacques TS; Swales A; Brzozowski MJ; Henriquez NV; Linehan JM; Mirzadeh Z; O' Malley C; Naumann H; Alvarez-Buylla A; Brandner S EMBO J; 2010 Jan; 29(1):222-35. PubMed ID: 19927122 [TBL] [Abstract][Full Text] [Related]
13. Innate neural stem cell heterogeneity determines the patterning of glioma formation in children. Lee DY; Gianino SM; Gutmann DH Cancer Cell; 2012 Jul; 22(1):131-8. PubMed ID: 22789544 [TBL] [Abstract][Full Text] [Related]
14. Glial progenitors as targets for transformation in glioma. Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528 [TBL] [Abstract][Full Text] [Related]
15. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625 [TBL] [Abstract][Full Text] [Related]
16. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Dougherty JD; Fomchenko EI; Akuffo AA; Schmidt E; Helmy KY; Bazzoli E; Brennan CW; Holland EC; Milosevic A Cancer Res; 2012 Sep; 72(18):4856-68. PubMed ID: 22865458 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217 [TBL] [Abstract][Full Text] [Related]
19. Premalignant Oligodendrocyte Precursor Cells Stall in a Heterogeneous State of Replication Stress Prior to Gliomagenesis. Sutcliffe MD; Galvao RP; Wang L; Kim J; Rosenfeld LK; Singh S; Zong H; Janes KA Cancer Res; 2021 Apr; 81(7):1868-1882. PubMed ID: 33531372 [TBL] [Abstract][Full Text] [Related]